In a very recent study, the immunomodulatory properties of CCN5 have been reported, according to which CCN5 can enhance the susceptibility of breast tumors to cytotoxic T‐lymphocyte (CTL)‐mediated lysis.10 Here, CCN5 is linked to breast neoplasm.